Skip to main content
Year archive

NEUREN PHARMACEUTICALS LIMITED — 2007 filings

All 53 regulatory filings released by NEUREN PHARMACEUTICALS LIMITED (NEU) in 2007, sourced directly from the official regulator.

53 Filings
2007 Period
2007 filings (53)
Filing Released Lang
Neuren announces non-renounceable rights issue 2 pages ?Kb
Capital/Financing Update
2007-12-18 English
D Clarke Appendix 3Z 2 pages ?Kb
Director's Dealing
2007-12-18 English
Rights Issue Letter of Offer 23 pages ?Kb
Share Issue/Capital Change
2007-12-18 English
Rights Issue NZ Investment Statement and Prospectus 44 pages ?Kb
Capital/Financing Update
2007-12-18 English
Appendix 3B - Non-renounceable Rights Issue 7 pages ?Kb
Share Issue/Capital Change
2007-12-18 English
Section 708AA Notice 2 pages ?Kb
Capital/Financing Update
2007-12-18 English
Shareholder Notice re Rights Issue 2 pages ?Kb
Capital/Financing Update
2007-12-18 English
Optionholder Notice re Rights Issue 2 pages ?Kb
Capital/Financing Update
2007-12-18 English
Foreign Shareholder Notice re Rights Issue 1 page ?
Capital/Financing Update
2007-12-18 English
Trading Halt 2 pages ?Kb
Regulatory Filings
2007-12-16 English
Neuren Clinical Development Update 5 pages ?Kb
Capital/Financing Update
2007-12-03 English
Neuren Corporate Update December 2007 38 pages ?Kb
Investor Presentation
2007-12-02 English
Neuren announces reorganisation 3 pages ?Kb
Board/Management Information
2007-11-11 English
NNZ-2566 successful Phase 1b trial results 3 pages ?Kb
Regulatory Filings
2007-11-06 English
Appendix 4C - quarterly 6 pages ?Kb
Interim / Quarterly Report
2007-10-30 English
Appendix 3B - issue of shares 7 pages ?Kb
Capital/Financing Update
2007-10-15 English
Appendix 3B - issue of convertible notes 8 pages ?Kb
Capital/Financing Update
2007-10-15 English
Notice under section 708A(5)(e) of the Corporations Act 1
Share Issue/Capital Change
2007-10-15 English
Neuren completes acquisition of Hamilton Pharmaceuticals 1
Capital/Financing Update
2007-10-15 English
MBP: Neural Regeneration Peptides (NRP) update - new animal 3 pages ?Kb
Regulatory Filings
2007-10-14 English
Results of Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2007-10-11 English
Notice of Special Meeting of Shareholders 16 pages ?Kb
Interim / Quarterly Report
2007-09-26 English
Neuren launches Australian Phase 3 Trial Sites 3 pages ?Kb
Regulatory Filings
2007-09-25 English
Neuren completes moderate TBI safety trial 3 pages ?Kb
Regulatory Filings
2007-09-19 English
Change in substantial holding 3 pages ?Kb
Regulatory Filings
2007-09-10 English
NZ arm of Phase 3 trial commences 2 pages ?Kb
Regulatory Filings
2007-09-06 English
Half Yearly Report and Accounts 18 pages ?Kb
Interim / Quarterly Report
2007-08-30 English
Corporate Update Presentation 31 pages ?Kb
Investor Presentation
2007-08-22 English
Acquisition of Motiva through Hamilton Pharmaceuticals 5 pages ?Kb
Capital/Financing Update
2007-07-30 English
Commitments test entity - second quarter 6 pages ?Kb
Interim / Quarterly Report
2007-07-30 English
Lapse of Unquoted Options 1 page ?Kb
Capital/Financing Update
2007-07-23 English
Cambridge University Alliance 1 page ?Kb
Regulatory Filings
2007-06-28 English
First patient enters Glypromate Phase 3 trial 3 pages ?Kb
Regulatory Filings
2007-05-30 English
CEO Presentation AGM 20 pages ?Kb
Regulatory Filings
2007-05-21 English
2007 AGM Results 1 page ?Kb
Regulatory Filings
2007-05-21 English
Revised Constitution 58 pages ?Kb
Regulatory Filings
2007-05-21 English
Bachem Glypromate Collaboration 2 pages ?Kb
Regulatory Filings
2007-05-13 English
Clinical Trials Update May 2007 4 pages ?Kb
Regulatory Filings
2007-05-09 English
Commitments Test Entity - First Quarter Report 6 pages ?Kb
Regulatory Filings
2007-04-29 English
Notice of Annual General Meeting 8 pages ?Kb
Regulatory Filings
2007-04-23 English
Annual Report 34 pages ?Kb
Regulatory Filings
2007-03-28 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2007-03-19 English
Preliminary Final Report 10 pages ?Kb
Regulatory Filings
2007-03-15 English
Substantial Security Holder Notice 1 page ?Kb
Regulatory Filings
2007-03-15 English
Neuren scientist receives Laureate award 2 pages ?Kb
Regulatory Filings
2007-02-25 English
Appendix 3B - ESOP options exercised 7 pages ?Kb
Regulatory Filings
2007-02-18 English
Further Validation of NNZ-2566 as TBI Treatment 6 pages ?Kb
Regulatory Filings
2007-02-12 English
US FDA approves Phase 3 IND for Glypromate Trial 2 pages ?Kb
Regulatory Filings
2007-01-30 English
Commitments Test Entity - Fourth Quarter Report 6 pages ?Kb
Regulatory Filings
2007-01-30 English
Appendix 3B - escrow period ending 3 February 2007 8 pages ?Kb
Regulatory Filings
2007-01-28 English
Successful NNZ-2566 safety trial results 2 pages ?Kb
Regulatory Filings
2007-01-16 English
Appendix 3B 7 pages ?Kb
Regulatory Filings
2007-01-16 English
CEO Presentation to Investors and Partners Jan 2007 32 pages ?Kb
Regulatory Filings
2007-01-11 English